Key result
Serum SHBG levels were significantly increased in patients with type 2 diabetes and initial stage diabetic retinopathy compared to obese controls without diabetes (89.0 vs 59.9 nmol/l).
Why the study?
Are serum SHBG levels elevated in patients with T2DM, obesity, and diabetic retinopathy compared to obese patients without T2DM?
Case-Control (n=99)
Are serum SHBG levels elevated in patients with T2DM, obesity, and diabetic retinopathy compared to obese patients without T2DM?
Absolute Event Rate: 89% vs 59.9%
Serum SHBG levels are significantly elevated in patients with type 2 diabetes and non-proliferative diabetic retinopathy compared to obese patients without diabetes.
No takes yet. Share an insight, caveat, or question.
Кирилюк et al. (2017) conducted a case-control in Type 2 diabetes mellitus, obesity, and diabetic retinopathy (n=99). Serum sex hormone-binding globulin (SHBG) level vs. Obese patients without T2DM was evaluated on Serum SHBG level. Serum SHBG levels were significantly increased in patients with type 2 diabetes and initial stage diabetic retinopathy compared to obese controls without diabetes (89.0 vs 59.9 nmol/l).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: